dehydroepiandrosterone has been researched along with ribavirin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bodeau, S; Brochot, E; Diouf, M; Duverlie, G; Lemouel, JP; Nguyen-Khac, E | 1 |
| Bodeau, S; Brochot, E; Domange, B; Duverlie, G; Garçon, L; Handala, L; Helle, F; Nguyen-Khac, E; Ouled-Haddou, H | 1 |
3 other study(ies) available for dehydroepiandrosterone and ribavirin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Hemoglobin during ribavirin-based HCV therapy is closely related to circulating levels of DHEA.
Topics: Adult; Aged; Anemia; Antiviral Agents; Dehydroepiandrosterone; Female; Hemoglobins; Hepatitis C, Chronic; Humans; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; Ribavirin; Sensitivity and Specificity; Young Adult | 2017 |
DHEA prevents ribavirin-induced anemia via inhibition of glucose-6-phosphate dehydrogenase.
Topics: Adenosine Triphosphate; Anemia; Antiviral Agents; Dehydroepiandrosterone; Erythrocytes; Glucosephosphate Dehydrogenase; Hemolysis; Hepatitis C, Chronic; Humans; Pentose Phosphate Pathway; Ribavirin | 2017 |